PA
IMNM icon

Profund Advisors’s Immunome IMNM Stock Holding History

Profund Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$903K Sell
42,635
-27,283
-39% -$584K 0.02% 372
2026
Q1 		$1.53M Buy
69,918
+27,218
+64% +$606K 0.06% 245
2025
Q4 		$917K Buy
42,700
+23,440
+122% +$411K 0.03% 372
2025
Q3 		$226K Buy
19,260
+2,723
+16% +$27.1K 0.01% 907
2025
Q2 		$154K Sell
16,537
-5,064
-23% -$41.5K 0.01% 936
2025
Q1 		$145K Buy
21,601
+5,507
+34% +$52.8K 0.01% 933
2024
Q4 		$171K Sell
16,094
-1,453
-8% -$17.6K 0.01% 1034
2024
Q3 		$257K Sell
17,547
-4,082
-19% -$58K 0.01% 897
2024
Q2 		$262K Buy
+21,629
New +$338K 0.01% 809

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Profund Advisors's IMNM Position: Q2 2026 in Review

Profund Advisors reduced its Immunome (IMNM) stake by 39% in Q2 2026, selling an estimated $584K and leaving 42,635 shares worth $903K. The position accounts for 0.02% of the portfolio, ranked #372.

Profund Advisors first reported a position in IMNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.53M in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Profund Advisors held 42,635 shares of Immunome worth $903K as of Q2 2026.
  • Profund Advisors sold 27,283 Immunome shares in Q2 2026, an estimated $584K.
  • Immunome made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #372 holding.
  • Profund Advisors first reported a position in Immunome in Q2 2024 and has held it in 9 quarters since.
  • Profund Advisors's Immunome position peaked at $1.53M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.